Medical Editor: John P. Cunha, DO, FACOEP
PrismaSol Solution (sterile hemofiltration/hemodiafiltration solution) is an electrolyte and buffer solution used as a replacement solution in Continuous Renal Replacement Therapy (CRRT) to replace plasma volume removed by ultrafiltration and to correct electrolytes and acid-base imbalances. PrismaSol Solution may also be used in cases of drug poisoning when CRRT is used to remove filterable substances. Common side effects of PrismaSol Solution include:
- fluid imbalance
- disturbances in electrolyte, acid-base, and glucose balance
- metabolic acidosis
- low blood pressure (hypotension)
- high phosphates in the blood (hyperphosphatemia) (for phosphate containing solutions)
The mode of therapy, solute formulation, flow rates and length of therapy with PrismaSol Solution is selected by a doctor depending on the clinical condition of the patient as well as the patient's fluid, electrolyte, acid-base and glucose balance. PrismaSol Solution may interact with other drugs. Tell your doctor all medications and supplements you use. Tell your doctor if you are pregnant or plan to become pregnant before using PrismaSol Solution. Consult your doctor before breastfeeding.
Our PrismaSol Solution (sterile hemofiltration/hemodiafiltration solution) Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
The following adverse reactions have been identified with other similar products and therefore, may occur with use of these products:
- Metabolic acidosis
- Acid-base disorders
- Electrolyte imbalance
- Hyperphosphatemia (for phosphate containing solutions)
- Fluid imbalance
Read the entire FDA prescribing information for PrismaSol Solution (Sterile Hemofiltration Hemodiafiltration Solution)
© PrismaSol Solution Patient Information is supplied by Cerner Multum, Inc. and PrismaSol Solution Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.